B-Cell Lymphoma

Featured

News
The rate of surveillance imaging of survivors of DLBCL decreased after the American Society of Hematology (ASH) Choosing Wisely campaign.
Videos
Karl Kilgore, PhD, discusses study results that showed greater HCRU and costs with CAR-T therapy than transplantation…
Videos
Karl Kilgore, PhD, discusses study results comparing patient characteristics, treatments, costs, and OS between…
Conference Coverage
HCRU and costs associated with CAR-T therapy were greater than transplantation for DLBCL and cost offsets before and…
Conference Coverage
Study results show polatuzumab vedotin plus bendamustine-rituximab is cost-effective in comparison to bendamustine-…